The institute would fund research on stem cells at Illinois universities and research facilities, based on recommendations from its board of medical and science experts. To receive funding, researchers would have to demonstrate a relevant record of achievement, contribute at least 20 percent in matching funds and sign an agreement giving Illinois a share in any revenue generated from commercialization of technology developed. Grantees would be prohibited from researching human cloning and would be required to produce annual progress reports and be audited by the Auditor General. The institute would be funded by a $1 billion bond issue to be repaid from revenue generated by a new, 6percent tax on elective cosmetic surgery procedures.

Hynes thinks the institute is necessary because Congress is proceeding cautiously on stem cells. As federal investment is curtailed, states are filling the gap. California passed a $3 billion bond referendum to fund stem cell research. New Jersey is funding stem cell research and proposing collaborative projects with Pennsylvania and Delaware. Wisconsin Gov. Jim Doyle wants to devote $750 million to that state's biotech research.

Additional information can find at:
suntimes.com
herald-meail.com